Physician

John Winchester Tole, D.O.

According to 2025 Medicare claims, John Tole, D.O. (NPI: 1568671584) practices allergy/immunology in the Auburn-Opelika, AL market, with the plurality of this provider's patient population coming from Lee, AL. This provider's primary affiliated billing organization is EAST ALABAMA ALLERGY AND ASTHMA, PLLC (NPI: 1396035101; TIN: 45-1272016) and primary practice location at 36830-5729.

Tole's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 178 traditional Medicare patients, billed 26,605 HCPCS/CPT codes, and received $812,652 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,755 prescription claims across 268 beneficiaries totaling $1,360,573 in drug costs, led by Glassia (Alpha-1-Proteinase Inhibitor). DME data shows 184 claims. Open Payments data shows 168 records totaling $12,644. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $68,615 to $812,652. Similarly, Part D prescription costs have moved sharply higher in recent years, from $183,852 to $1,360,573. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $360 and ending at $2,309.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	259	8,364	$68,615
2016	264	7,554	$61,904
2017	215	5,590	$45,222
2018	179	4,972	$44,207
2019	204	5,911	$47,957
2020	105	1,856	$17,042
2021	189	4,562	$45,519
2022	157	6,902	$110,906
2023	186	21,560	$398,920
2024	178	26,605	$812,652

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	203	1,177	$183,852
2016	214	1,373	$169,184
2017	234	1,433	$321,936
2018	233	1,486	$461,646
2019	231	1,273	$553,300
2020	161	789	$354,617
2021	158	742	$164,305
2022	116	621	$228,093
2023	181	809	$338,724
2024	268	1,755	$1,360,573

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$126
2016	N/R	83	$44,718
2017	N/R	48	$1,939
2018	N/R	47	$870
2019	N/R	138	$168,601
2020	N/R	223	$264,552
2021	N/R	237	$250,396
2022	N/R	246	$196,721
2023	N/R	138	$135,487
2024	N/R	184	$215,349

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	94	113	$81
94010	Test to measure expiratory airflow and volume	36	44	$17
95012	Test to measure the level of nitric oxide gas	32	42	$12
36415	Insertion of needle into vein for collection of blood sample	32	42	$8
95165	Professional service for preparation and provision of 1 or more antigens	32	315	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Glassia	Alpha-1-Proteinase Inhibitor	12	336	$232,877
Dupixent Syringe	Dupilumab	47	1,316	$172,957
Nucala	Mepolizumab	43	1,204	$156,688
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	17	476	$137,452
Dupixent Pen	Dupilumab	25	700	$94,060

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	48	$128,066
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	12	$55,319
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	13	$30,001
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	38	$1,433
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	54	$445

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	166	$10,894	Consortium of Independent Immunology Clinics, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$1,750	Consortium of Independent Immunology Clinics, LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$34,238	Consortium of Independent Immunology Clinics, LLC

Explore More Providers

FAQ

What Medicare data is available for John Winchester Tole, D.O.?

Tedicare shows public-source Medicare data for John Winchester Tole, D.O. (NPI 1568671584), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Winchester Tole, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Winchester Tole, D.O.?

John Winchester Tole, D.O. is linked to EAST ALABAMA ALLERGY AND ASTHMA, PLLC (billing NPI 1396035101) in the available physician profile data.

Does John Winchester Tole, D.O. have Open Payments data?

John Winchester Tole, D.O. has 168 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.